Retatrutide 40mg

High-Potency Triple Agonist Peptide for Advanced Metabolic Research

Retatrutide 40mg is a high-purity, research-grade peptide being investigated for its potential effects on weight management, glucose regulation, energy expenditure, and overall metabolic health. As a triple hormone receptor agonist, Retatrutide simultaneously activates GIP (Glucose-Dependent Insulinotropic Polypeptide), GLP-1 (Glucagon-Like Peptide-1), and glucagon receptors. This innovative three-pathway mechanism has positioned Retatrutide as one of the most promising investigational peptides for obesity and metabolic disease research.

The 40mg formulation provides a higher peptide content for extended laboratory research protocols while maintaining exceptional purity, stability, and consistency.

Product Highlights

• Peptide: Retatrutide (LY3437943)
• Strength: 40mg per vial
• Category: Triple GIP, GLP–1 & Glucagon Receptor Agonist
• Form: Lyophilized (freeze-dried) peptide powder
• Administration: Reconstituted for subcutaneous injection in research settings
• Quality: High-purity research-grade peptide

What Is Retatrutide Made Of?

Retatrutide is a synthetic peptide engineered to activate the body’s GIP, GLP-1, and glucagon receptors simultaneously. Its molecular structure incorporates modifications that improve stability and extend its duration of action, supporting once-weekly administration in clinical research studies.

What Is Retatrutide Studied For?

Retatrutide is currently being studied for its potential role in:

• Supporting healthy weight management
• Improving blood glucose regulation
• Enhancing insulin sensitivity
• Reducing appetite and food intake
• Increasing feelings of fullness (satiety)
• Increasing energy expenditure
• Supporting fat metabolism and fat oxidation
• Improving overall metabolic health
• Investigating obesity, type 2 diabetes, obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease (MASLD), and other obesity-related conditions in ongoing clinical trials.

Potential Benefits

• Supports metabolic and obesity research
• May promote healthy body weight
• May reduce appetite and food cravings
• Supports healthy blood glucose metabolism
• May increase calorie expenditure
• High-purity peptide for laboratory research
• Designed for convenient once-weekly administration in clinical trials

How It Works

Retatrutide activates three key hormone receptors involved in metabolic regulation:

• GLP-1 receptors to promote satiety, reduce appetite, and slow gastric emptying.
• GIP receptors to support glucose-dependent insulin secretion and improve metabolic function.
• Glucagon receptors to increase energy expenditure and enhance fat utilization.

The combined activation of these three pathways is being investigated for potentially greater effects on weight management and metabolic health than therapies targeting only one or two of these receptors.

Storage

• Store the unopened lyophilized vial in a cool, dry place.
• After reconstitution, refrigerate according to laboratory protocol.
• Protect from excessive heat, moisture, and direct light.
• Do not use if the solution becomes cloudy or contains particulate matter.